No Data
Intelligent Bio Solution Launches Validation Study Targeting A Significant Reduction In The Time Required To Analyze Its Intelligent Fingerprinting Drug Screening System
Intelligent Bio Solutions Updates Investor Presentation and Share Count
Intelligent Bio Solutions Completes Penetration Testing As Part Of Its Upcoming FDA Submission
Intelligent Bio Solutions Shares Are Trading Lower. The Company Said It Completed Initial Clinical Cut-off Study Supporting Its FDA 510(k) Submission for U.S. Market Clearance of Its Intelligent Fingerprinting Drug Screening System for Detection of...
Intelligent Bio Solutions Completes Its Initial Clinical Cut-Off Trial For FDA 510(k) Submission For U.S. Market Clearance Of Its Intelligent Fingerprinting Drug Screening System
Express News | Intelligent Bio Solutions Inc: Completion of Interference Study Is Anticipated by End of July 2026